Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-24
Closed -$1.15K 1163
2023
Q1
$1.15K Buy
24
+8
+50% +$407 ﹤0.01% 1143
2022
Q4
$848 Sell
16
-18
-53% -$887 ﹤0.01% 1236
2022
Q3
$1K Buy
34
+10
+42% +$494 ﹤0.01% 1221
2022
Q2
$1K Buy
+24
New +$1.17K ﹤0.01% 1258

Other funds holding QGEN

Schubert & Co's QGEN Position: Q2 2023 in Review

Schubert & Co sold out of Qiagen (QGEN) in Q2 2023, closing a stake of 24 shares — an estimated $1.15K sold.

Schubert & Co first reported a position in QGEN in Q2 2022 and held it in 4 quarters. The position peaked at $1.15K in Q1 2023. 282 funds tracked by Wall St. Rank hold QGEN as of Q2 2023.

  • Schubert & Co reported no remaining Qiagen position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 24 Qiagen shares in Q2 2023, an estimated $1.15K.
  • Schubert & Co first reported a position in Qiagen in Q2 2022 and held it in 4 quarters.
  • Schubert & Co's Qiagen position peaked at $1.15K in Q1 2023.
  • 282 funds tracked by Wall St. Rank held Qiagen as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.